We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Human Granulocytic Anaplasmosis Confirmed by Molecular Assay

By LabMedica International staff writers
Posted on 26 Mar 2012
Human granulocytic anaplasmosis (HGA) is a tick-borne infection, yet few clinical cases have been diagnosed by a positive polymerase chain reaction (PCR) assay. More...


Subsequent seroconversion against the antigen of the causative intraerythrocytic agent, Anaplasma phagocytophilum, would fulfill the epidemiologic, clinical, and biological criteria for HGA, which is characterized by an acute, nonspecific febrile illness.

At the Hôpitaux Universitaires de Strasbourg (France), 15 patients presented with a febrile syndrome with a recent history of tick bites or exposures to ticks were tested for HGA, during the period June to September 2009. Whole blood samples with ethylenediaminetetraacetic acid (EDTA) were systematically collected for blood smear and specific PCR assay during the febrile phase of the disease. For serologic testing, two sera were also collected: the first during the acute phase and the second two to three weeks afterwards, during the convalescent phase.

DNA was extracted from whole-blood samples and real-time PCR was performed on the ABI Prism 7000 SDS (Applied Biosystems; Foster City, CA, USA). Serologic diagnosis of infection with A. phagocytophilum was made by immunofluorescent antibody test (IFA) (Focus Diagnostics, Cypress, CA, USA). Serum specimens with immunoglobulin M (IgM) titers of equal or greater than 1:40 and IgG titers equal to or greater than 1:64 were considered positive. Blood smears were obtained from whole blood samples, stained with May-Grünwald-Giemsa and examined for the presence of morulae within the cytoplasm of neutrophils

Molecular testing using the major surface protein 2 (msp2)/p44 gene yielded positive results in the acute-phase blood of three of the 15 patients tested. For the 12 patients with negative PCR assay, microscopic examination was negative and no specific antibodies were detected in acute-phase serum. Laboratory findings were available for 6 patients among the 12 with a negative PCR assay; all these 6 presented leucopenia, thrombocytopenia, and increased levels of liver enzymes. For the three patients with positive PCR results, examination of peripheral blood smears revealed cytoplasmic inclusions suggestive of A. phagocytophilum morulae and elevated serum levels of liver enzymes.

The authors concluded that a specific PCR assay on EDTA anticoagulated blood may be the diagnostic test of choice for HGA during the first two weeks following the onset of symptoms, allowing a faster diagnosis than serology. HGA should be included in the differential diagnosis of patients presenting febrile illness associated with bicytopenia, elevated rates of liver enzymes, increased C-reactive protein values, and whose medical history reveals recent exposure to ticks. The study was published in the March 2012 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Hôpitaux Universitaires de Strasbourg
Applied Biosystems
Focus Diagnostics



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is FDA-cleared for use in diagnosing Alzheimer’s (Photo courtesy of Fujirebio)

First FDA Cleared Blood Test for Alzheimer’s Diagnosis Marks Turning Point in Early Detection

Alzheimer’s disease is a progressive form of dementia that affects memory, cognition, and behavior, eventually interfering with daily activities. Early and accurate diagnosis is essential to improving... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.